The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Becton Dickinson and Co

NYSE: BDX
Last

(U.S.) $140.33

Today's change-0.93 -0.66%
Updated November 28 1:09 PM EST. Delayed by at least 15 minutes.
 

Becton Dickinson and Co

NYSE: BDX
Last

(U.S.) $140.33

Today's change-0.93 -0.66%
Updated November 28 1:09 PM EST. Delayed by at least 15 minutes.

Reversal following new 52-week high

Becton Dickinson and Co closed lower Friday, dropping (U.S.)$0.93 or 0.66% to (U.S.)$140.33 after setting a new 52-week high. Over the last five days, shares have gained 7.63% and are currently 1.41% off of the 52-week high. Shares have outperformed the S&P 500 by 14.41% during the last year.

Key company metrics

  • Open(U.S.) $141.52
  • Previous close(U.S.) $141.26
  • High(U.S.) $142.33
  • Low(U.S.) $139.97
  • Bid / Ask-- / --
  • YTD % change+27.01%
  • Volume868,773
  • Average volume (10-day)1,324,786
  • Average volume (1-month)1,168,542
  • Average volume (3-month)1,533,298
  • 52-week range(U.S.) $104.94 to (U.S.) $142.33
  • Beta0.89
  • Trailing P/E23.36×
  • P/E 1 year forward20.78×
  • Forward PEG2.88×
  • Indicated annual dividend(U.S.) $2.40
  • Dividend yield1.71%
  • Trailing EPS(U.S.) $6.01
Updated November 28 1:09 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+14.02%

Based on its net profit margin of 14.02%, Becton Dickinson and Co is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.19%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue2,2022,1572,0722,014
Total other revenue--------
Total revenue2,2022,1572,0722,014
Gross profit1,1031,1111,0531,034
Total cost of revenue1,0991,0461,019980
Total operating expense1,8011,7121,6911,636
Selling / general / administrative561528525531
Research & development140137147126
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total110-1
Operating income401445381378
Interest income (expense), net non-operating-36-33-33-34
Gain (loss) on sale of assets--------
Other--------
Income before tax376423363359
Income after tax300326287271
Income tax, total76977688
Net income300326287271
Total adjustments to net income1------
Net income before extra. items300326287271
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items301326287271
Inc. avail. to common incl. extra. items301326287271
Diluted net income301326287271
Dilution adjustment--------
Diluted weighted average shares196197197198
Diluted EPS excluding extraordinary itemsvalue per share1.531.651.451.37
Dividends per sharevalue per share0.550.550.550.55
Diluted normalized EPSvalue per share1.531.651.451.37